02-3471-4100 info@chayon.co.kr
Select Page


AnaBios는 Drug Discovery의 모든 단계에 Human Tissue Sample 및 Service를 제공합니다.


ico_chk01 Physiologically Functional Tissue for Drug Discovery

– AnaBios는 기증에 동의한 성인들로부터 윤리적으로 공급받은 high-quality adult human tissue를 제공합니다.
– Diseased 또는 normal tissue 모두 제공 가능하며 성별, 나이, 인종, BMI를 포함한 인구통계학적 정보를 제공합니다.

Human Tissue Diseased Tissue Types Uses
Liver  Please inquire

cirrhosis, NASH, NAFLD

Liver samples (bulk and punch), frozen hepatocytes Genomic sequencing (tissue)

RNAscope, proteomics, IHC

[Human Liver Tissue Regions]

Item Cat # Item Cat # Item Cat #
Coronary Ligament CAR-104/F Coronary Ligament – NASH CAR-104/F Coronary Ligament – NAFLD CAR-104/F
Dextrose Cells CAR-108/F Dextrose Cells – NASH CAR-108/F Dextrose Cells – NAFLD CAR-108/F
Gall Bladder CAR-109/F Gall Bladder – NASH CAR-106/F Gall Bladder – NAFLD CAR-106/F
Left Lobe CAR-101/F Left Lobe – NASH CAR-101/F Left Lobe – NAFLD CAR-101/F
Portal Vein CAR-107/F Portal Vein – NASH CAR-107/F Portal Vein – NAFLD CAR-107/F
Right Lobe CAR-103/F Right Lobe – NASH CAR-103/F Right Lobe – NAFLD CAR-103/F
α-Lipoic Acid Cells CAR-109/F α-Lipoic Acid Cells – NASH CAR-109/F α-Lipoic Acid Cells – NAFLD CAR-109/F
α-Lipoic Acid + Dextrose CAR-110/F α-Lipoic Acid + Dextrose – NASH CAR-110/F α-Lipoic Acid + Dextrose – NAFLD CAR-110/F


Primary Human Hepatocytes (PHHGs) Application :


  • Drug screening
  • Clearance study
  • Regulatory induction
  • Long-term metabolic stability
  • Toxicity
  • Transporter studies
  • Co-culturing
  • Genomics

[Primary Human Hepatocytes (PHHGs) Tissue Regions]

Item Cat #
Cryo suspension Hepatocytes HEP-001
Cryo plateable Hepatocytes HEP-002
Plating Medium HEP-003
Maintenance Medium HEP-004

Major Cell Types :

  • Stellate
  • Kupffer
  • Liver Sinusoidal Endothelial
  • Hepatocytes.


PHH lot based on yield, viability, morphology and plating efficiency.
Each lot is guaranteed to contain a minimum of 3-6 million cells per vial.
* All lot-specific information will be reported on the Certificate of Analysis (CoA)

Each lot is evaluated for : Donor information :
Post-thaw viability ≥ 75% death, age, gender, race, BMI, diabetic status, smoking history, alcohol use, drug history & co-morbidities
Confluency > 70% on Day 5
CYP1A2, CYP2B6 and CYP3A4 induction
Metabolic activity of CYP450: 1A2, 2B6, 2C8, 2C9, 2C19, 2D6, 3A, GEN, SULT, UGT, AO
Serology results (via PCR detection) : Culture results :
HBV, HCV, HIV-1, HIV-2, CMV, EBV, SARS-CoV-2 mycoplasma, fungi, yeast, Gram + and Gram -.

제품 & 서비스 문의

관심분야 (중복선택가능)

개인정보 취급 방침 동의